Search

Your search keyword '"Martin H.N. Tattersall"' showing total 343 results

Search Constraints

Start Over You searched for: Author "Martin H.N. Tattersall" Remove constraint Author: "Martin H.N. Tattersall"
343 results on '"Martin H.N. Tattersall"'

Search Results

1. <scp>PD</scp> ‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma

2. A randomised controlled trial of an advance care planning intervention for patients with incurable cancer

Catalog

Books, media, physical & digital resources

3. Supporting doctor-patient communication: Providing a question prompt list and audio recording of the consultation as communication aids to outpatients in a cancer clinic

4. Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk

5. What do patients with cancer and their families value most at the end of life? A critical analysis of advance care planning

6. Gaps in patients’ understanding of palliative chemotherapy. Can we better communicate that treatment is not curative?

7. 'Standard Care' in Cancer Clinical Trials: An Analysis of Care Provided to Women in the Control Arms of Breast Cancer Clinical Trials

8. Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study

9. Improving hospital-based end of life care processes and outcomes: a systematic review of research output, quality and effectiveness

10. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists

11. Advance Care Planning: is quality end of life care really that simple?

12. Preferences for life expectancy discussions following diagnosis with a life-threatening illness: a discrete choice experiment

13. Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients

14. Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

15. Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse

16. International survey of awareness of genetic risk in the clinical sarcoma community

17. Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

18. Advance care planning for cancer patients: a systematic review of perceptions and experiences of patients, families, and healthcare providers

19. Timing and context: important considerations in the return of genetic results to research participants

20. Patient-Oncologist Communication: Sharing Decisions in Cancer Care

21. Bereaved and aggrieved in the age of social media

22. How Well Do Current Measures Assess the Impact of Advance Care Planning on Concordance Between Patient Preferences for End-of-Life Care and the Care Received: A Methodological Review

23. FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center

24. Misunderstandings, mandatory biopsies, and conflicts of interests in clinical trials: a coercive cocktail?

25. Patient autonomy and advance care planning: a qualitative study of oncologist and palliative care physicians' perspectives

26. Achieving shared treatment decisions

27. Discussing prognosis and communicating risk

28. Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors

29. A qualitative analysis of responses to a question prompt list and prognosis and end-of-life care discussion prompts delivered in a communication support program

30. Li-Fraumeni syndrome: cancer risk assessment and clinical management

31. Fidelity is fundamental: intervention predictors in advance care plans in terminal cancer

32. Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients

33. Physician–patient–companion communication and decision-making: A systematic review of triadic medical consultations

34. Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial

35. Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer

36. Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma

37. Adapting an Australian question prompt list in oncology to a Norwegian setting-a combined method approach

38. Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials

39. Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience

40. Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008

41. Three questions that patients can ask to improve the quality of information physicians give about treatment options: A cross-over trial

42. Factors which motivate cancer doctors to involve their patients in reaching treatment decisions

43. Identifying patient information needs about cancer clinical trials using a Question Prompt List

44. How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials

45. Conflicts of interest: a review of institutional policy in Australian medical schools

46. Factors associated with Australian and New Zealand oncologists' future work preferences

47. P1.04-11 Exploring the Germ-Line Contribution to Exceptional Response to PD-1/PD-L1 Inhibition in Patients with NSCLC by Whole Genome Sequencing

48. Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing

49. Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations

50. Enhancing decision making about participation in cancer clinical trials: development of a question prompt list